On this episode, I interview Sam Whitaker, Co-Founder & Co-CEO of Mural Health. Mural Health is a clinical trials technology company that is dedicated to making it easy to be a participant in clinical trials.
Mural Health’s technology platform, Mural Link, is a patient-first technology that is primarily designed to benefit the study participant but also improves site operations and drives critical strategic value to study sponsors.
Prior to Mural Health, Sam founded Greenphire, a leading provider of clinical payment and communication solutions. Over 13 years, the company grew and eventually reaching a value of over a billion dollars with only 2.2 million raised from investors.
After a successful exit with Greenphire, Sam co-founded Mural Health, a next-generation participant payment solution that modernizes the way research sites execute payments and participants receive them.
Mural Health also provides additional features that make it easier for participants, taking advantage of modern tech and the widespread acceptance of mobile applications.
Despite the challenges and difficulties of starting another business in the clinical trial space, Sam was motivated to start Mural Health for reasons different from those that led him to start Greenphire.
Listen to Sam share his career journey revolutionizing the payments and clinical trial space, why he built Greenphire and now Mural Health, and his mission to modernize the way research sites handle transactions and the participant experience.
Learn more at https://www.muralhealth.com/
---
This episode is sponsored by Brinker Simpson & Company